KRAS Mutation Status in Non-Small Cell Lung Cancer Distribution Across Occupational Categories
CHEST · 2025
DOI: 10.1016/j.chest.2025.06.043 ↗Kurz gefasst
Fachartikel in der Zeitschrift CHEST, 2025. Verfasst von Roberto Serna-Blasco und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain; Liquid Biopsy Laboratory, Department of…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Proto-Oncogene Proteins p21(ras), Occupational Exposure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: H2020 European Institute of Innovation and Technology, European Social Fund Plus, Horizon 2020 Framework Programme.
Abstract (Originalsprache)
BACKGROUND: Lung cancer remains the leading cause of cancer-related deaths worldwide, with occupational carcinogen exposure contributing significantly to its etiology. However, the molecular mechanisms underlying this process remain largely unexplored. RESEARCH QUESTION: Does occupational exposure to specific carcinogens influence the molecular profile of metastatic non-small cell lung cancer (NSCLC)? STUDY DESIGN AND METHODS: A total of 302 patients with metastatic NSCLC without activating EGFR/ALK mutations were included, all of whom provided detailed occupational histories. Jobs were classified according to the International Standard Classification of Occupations (ISCO), an Adapted Classification (AC), and the carcinogenic exposure-based International Agency for Research on Cancer Classification (IARCC). Tumor biopsy specimens were analyzed by using next-generation sequencing. Comparisons were performed between each category and the rest of the cohort. RESULTS: Pairwise comparisons revealed significantly higher prevalence of KRAS mutations among cooks (AC; P = .035), whereas painters showed a trend toward significance (AC; P = .067). These associations were confirmed in multivariate analyses adjusted for sex and smoking status, with ORs of 5.81 (95% CI, 1.41-23.93) for cooks and 4.29 (95% CI, 1.03-17.91) for painters. Similarly, Personal Service Workers (ISCO) and Building and Related Trades Workers (ISCO) exhibited higher KRAS mutation prevalence (P = .003 and P = .027, respectively), which remained significant in multivariate analyses (OR of 5.46 [95% CI, 1.83-16.34] and 3.31 [95% CI, 1.18-9.26]). Conversely, lower KRAS mutation frequencies were observed among Information and Communications Technology Professionals (ISCO) (P = .031), office workers (AC; P = .002), and workers with low/no exposure (IARCC; P = .005). These associations were confirmed in multivariate models (OR of 0.34 [95% CI, 0.18-0.66] and 0.43 [95% CI, 0.25-0.75] for AC and IARCC). Finally, distinct distributions of KRAS mutation subtypes were found across occupations. Personal Service Workers (ISCO) were enriched for the G12C mutation (P = .012), painters for G12A (AC; P = .020), and chemically exposed workers for G12D (IARCC; P = .005). INTERPRETATION: Our results suggest that occupational exposure is associated with distinct KRAS mutation prevalence in NSCLC, with different mutation patterns across job categories.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain; Liquid Biopsy Laboratory, Department of Medical Oncology, Hospital Universitario Puerta de Hierro Majadahonda…
- Department of Oncology, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Islas Canarias, Spain.
- Department of Oncology, Hospital Universitario Basurto, Bilbao, País Vasco, Spain.
- Department of Oncology, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Islas Canarias, Spain.
- Complejo Público Asistencial de Zamora, Hospital Virgen de la Concha, Zamora, Castilla y León, Spain.
- Department of Oncology, Hospital Universitario Clínico San Carlos, Madrid, Comunidad de Madrid, Spain.
Förderung
- H2020 European Institute of Innovation and Technology
- European Social Fund Plus
- Horizon 2020 Framework Programme
- Spain Ministry of Education Vocational Training and Sports
- Carlos III Health Institute
- European Regional Development Fund
Zitieren
APA
Serna-Blasco, R., Medina, K., Sala, M. Á., Aguiar, D., Díaz-Serrano, A., Antoñanzas, M., González Larriba, J. L., Ocaña, J., Mielgo, X., Fernández, I., López-Castro, R., Cobo, M., Martínez, M., Villa, J. C., Rosado, P., López, A., Guirado, M., Viteri, S., Rodríguez, D., …, & Provencio, M. (2025). KRAS Mutation Status in Non-Small Cell Lung Cancer Distribution Across Occupational Categories. CHEST. https://doi.org/10.1016/j.chest.2025.06.043
Vancouver
Serna-Blasco R, Medina K, Sala MÁ, Aguiar D, Díaz-Serrano A, Antoñanzas M, et al. KRAS Mutation Status in Non-Small Cell Lung Cancer Distribution Across Occupational Categories. CHEST. 2025. doi:10.1016/j.chest.2025.06.043
BibTeX
@article{SernaBlasco2025,
author = {Serna-Blasco, Roberto and Medina, Karla and Sala, María Ángeles and Aguiar, David and Díaz-Serrano, Asunción and Antoñanzas, Mónica and González Larriba, José Luis and Ocaña, Julio and Mielgo, Xabier and Fernández, Inmaculada and López-Castro, Rafael and Cobo, Manuel and Martínez, Mireia and Villa, José Carlos and Rosado, Petra and López, Ana and Guirado, María and Viteri, Santiago and Rodríguez, Delvys and García, Florencia and Simón, Soraya and Moreno, María Ángeles and Catot, Silvia and Mediavilla-Medel, Pilar and García-Simón, Natalia and Octavio, Leonor and Calvo, Virginia and Romero, Atocha and Provencio, Mariano},
title = {KRAS Mutation Status in Non-Small Cell Lung Cancer Distribution Across Occupational Categories},
journal = {CHEST},
year = {2025},
doi = {10.1016/j.chest.2025.06.043}
}
EUVIMED